EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

AB ‐ MDMSBA —Not a Synthetic Cannabinoid Receptor Agonist

Monica Patel iD, Dharshini Ganeshan, Izzy Horgan, Hannah Partington iD, Michelle Glass iD

Pharmacology Research & Perspectives · 2026-06 · 14 (3)

DOI: 10.1002/prp2.70278 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, online erschienen am 08.06.2026. Verfasst von Monica Patel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, University of Otago, Dunedin, New Zealand. Hauptthemen laut MEDLINE: Receptor, Cannabinoid, CB1, Cannabinoid Receptor Agonists, Cannabinoids. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Division of Health Sciences, University of Otago, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synthetic cannabinoids remain one of the most prominent classes of New Psychoactive Substances (NPS). The introduction of “blanket bans” has only invigorated the development and emergence of novel compounds. Recently, a putative synthetic cannabinoid, AB‐MDMSBA, was identified in Australia and New Zealand, with little to no pharmacological data on this compound. This current study, therefore, aimed to determine the potential activity of AB‐MDMSBA at the human cannabinoid CB 1 receptor. Results revealed AB‐MDMSBA failed to activate cAMP and β‐arrestin 2 pathways, or to induce a conformational change in a CB 1 biosensor, unlike the known synthetic agonist AMB‐FUBINACA, suggesting the compound is not a synthetic cannabinoid. These findings may aid in drug classification and the identification of structurally similar compounds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Cannabinoid, CB1Cannabinoid Receptor AgonistsCannabinoidsHumansCyclic AMPHEK293 CellsIndazolesbeta-Arrestins

Stichwörter der Autor:innen

cannabinoid CB1 receptorsynthetic cannabinoid receptor agonisttoxicity

Substanzen

Receptor, Cannabinoid, CB1Cannabinoid Receptor AgonistsCannabinoidsCyclic AMPAB-FUBINACAIndazolesbeta-Arrestins

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, University of Otago, Dunedin, New Zealand.
  • New Zealand Institute for Public Health and Forensic Science (PHF Science), Auckland, New Zealand.

ORCID-Profile: Monica Patel, Hannah Partington, Michelle Glass

Förderung

  • Division of Health Sciences, University of Otago
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Patel, M., Ganeshan, D., Horgan, I., Partington, H., & Glass, M. (2026). AB ‐ MDMSBA —Not a Synthetic Cannabinoid Receptor Agonist. Pharmacology Research & Perspectives, 14(3). https://doi.org/10.1002/prp2.70278

Vancouver

Patel M, Ganeshan D, Horgan I, Partington H, Glass M. AB ‐ MDMSBA —Not a Synthetic Cannabinoid Receptor Agonist. Pharmacology Research & Perspectives. 2026;14(3). doi:10.1002/prp2.70278

BibTeX
@article{Patel2026,
  author = {Patel, Monica and Ganeshan, Dharshini and Horgan, Izzy and Partington, Hannah and Glass, Michelle},
  title = {AB ‐ MDMSBA —Not a Synthetic Cannabinoid Receptor Agonist},
  journal = {Pharmacology Research & Perspectives},
  year = {2026},
  volume = {14},
  number = {3},
  doi = {10.1002/prp2.70278}
}
Kostenlos starten →